High rate of prescriptions for new cholesterol medications never filled

In the first year of availability of the cholesterol lowering medications PCSK9 inhibitors, fewer than 1 in 3 adults initially prescribed one of these inhibitors actually received it, owing to a combination of out-of-pocket costs and lack of insurance approval, according to a study.

This post was syndicated from Top Health News -- ScienceDaily. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply